Joel Spaltenstein

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background CMR is an established method for the diagnosis and assessment of myocardial infarction in routine exams. In addition, there has been a growing interest in using infarct size as a surrogate endpoint for clinical trials assessing the efficacy of acute MI reperfusion treatments and MI size is reported to be a stronger predictor of outcome than LVEF(More)
  • 1